Abstract
In this study, we investigated the molecular mechanism of doxorubicin (dxr)-induced cytotoxicity on Jurkat cells - a model cell of human acute lymphoblastic leukemia - under normoxic (20% O2) and hypoxic (5% O2) conditions. Using in-cell western analysis, immunofluorescence, flow cytometry analysis, and biochemical inhibitors, we evaluated several oxidative stress (OS) and cell death markers. It was found that dxr (5-100 μmol/l) induced apoptosis by OS mechanisms involving DNA fragmentation (8-48%), loss of mitochondrial membrane potential (ΔΨm, 33-92%), and H2O2 production (15-42%) under normoxia. In addition, dxr (10 μmol/l) induced activation and/or nuclei translocation of NF-κB (6.6, 1.6-fold increase), p53 (4.3, 3.1 f), c-Jun (9.5, 5.0 f), apoptosis-inducing factor (AIF) (1.9, 3.9 f), caspase-3 (3.7, 1.9 f), overexpression of Parkin (2.1, 1.2 f)/PINK-1 (2.1 f) proteins, and reduced DJ-1 levels by half compared with untreated cells under normoxia, according to immunofluorescence and in-cell western analysis, respectively. In contrast, dxr (10 μmol/l) could not induce apoptosis in Jurkat cells under hypoxia. Effectively, dxr significantly reduced DNA fragmentation (6%), expression levels of cell death (e.g. p53, c-Jun, caspa...Continue Reading
References
Mar 13, 1999·Biochemical Pharmacology·D A Gewirtz
Jun 24, 2000·Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology·M LeiteJ E Guimarães
Jul 27, 2000·Experimental Cell Research·S GamenJ Naval
Feb 28, 2001·Antioxidants & Redox Signaling·O InanamiM Kuwabara
May 23, 2002·FEBS Letters·Hideaki KamataHajime Hirata
Apr 25, 2003·The Journal of Biological Chemistry·Yasunari TakadaBharat B Aggarwal
Aug 6, 2003·Life Sciences·W P TsangT T Kwok
Aug 9, 2003·Biochemical Pharmacology·Cheryl Brantley-FinleyTimothy C Chambers
Dec 31, 2003·Biochemical Pharmacology·Kazuhiro AshikawaBharat B Aggarwal
Apr 1, 2004·Molecular Cell·Kirsteen J CampbellNeil D Perkins
Oct 9, 2004·Science·Andrew P WengJon C Aster
Oct 14, 2004·Cancer·Hagop KantarjianEmil J Freireich
Feb 1, 2005·Life Sciences·Hideki MizutaniShosuke Kawanishi
May 19, 2005·Cancer Research·Wai Chi HoPhilip A Barker
Nov 16, 2005·International Journal of Cancer. Journal International Du Cancer·Xabier AgirreFelipe Prósper
Aug 5, 2006·Molecular Pharmacology·Qingdong Ke, Max Costa
Aug 12, 2006·Brain Research·Charlesene McNeill-BlueB Alex Merrick
Sep 22, 2006·The European Journal of Neuroscience·Yan Xiang YangDavid S Latchman
Feb 23, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Iris H HennKonstanze F Winklhofer
Aug 30, 2008·Biochemical and Biophysical Research Communications·Hang LiuJianxiang Wang
Oct 11, 2008·Cell Death and Differentiation·G KroemerUNKNOWN Nomenclature Committee on Cell Death 2009
Oct 30, 2008·Blood·Michael FieglMichael Andreeff
Mar 5, 2009·Pediatric Blood & Cancer·Stefanie R LowasSuman Malempati
Sep 12, 2009·PloS One·Brian K BednarskiHong Jin Kim
Nov 3, 2009·Human Molecular Genetics·Di ShaLian Li
Nov 17, 2009·Cell Death and Differentiation·M F van DelftJ M Adams
Feb 9, 2010·Trends in Biochemical Sciences·Emilie HangenNazanine Modjtahedi
Mar 2, 2010·Biochemical Pharmacology·Nuria López-RoyuelaIsabel Marzo
Aug 14, 2010·PloS One·Nadine RohwerThorsten Cramer
Sep 4, 2010·Antioxidants & Redox Signaling·Mark A Wilson
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Apr 5, 2011·Autophagy·Nickie C Chan, David C Chan
Apr 7, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Nadine Rohwer, Thorsten Cramer
Jul 16, 2011·Cell Death and Differentiation·L GalluzziG Kroemer
Jul 21, 2011·Molecular Pharmaceutics·Chung-Pu WuYu-Shan Wu
Aug 20, 2011·PloS One·Juliana BenitoMarina Konopleva
Sep 21, 2011·Proceedings of the National Academy of Sciences of the United States of America·Cen ZhangZhaohui Feng
Nov 15, 2011·Cell·Yaron Fuchs, Hermann Steller
Feb 23, 2012·EMBO Reports·Andrew W GreeneEdward A Fon
May 23, 2012·Chemico-biological Interactions·Juan Ignacio AguilóMaría Angeles Alava
May 24, 2012·Oxidative Medicine and Cellular Longevity·Marlene Jimenez-Del-Rio, Carlos Velez-Pardo
Jun 23, 2012·Open Biology·Chandana KondapalliMiratul M K Muqit
Jul 13, 2012·Cancer Biology & Therapy·Olga FrolovaMarina Konopleva
Aug 23, 2012·Nature Communications·Kei OkatsuNoriyuki Matsuda
Aug 31, 2012·Anti-cancer Agents in Medicinal Chemistry·Albert BreierZdenka Sulova
Sep 7, 2012·Cold Spring Harbor Perspectives in Medicine·Mark R Cookson
Dec 21, 2012·ELife·Bray DenardJin Ye
Jan 3, 2013·The Journal of Pharmacy and Pharmacology·Oktay TacarCrispin R Dass
Jan 16, 2013·Oxidative Medicine and Cellular Longevity·Miguel Mendivil-PerezMarlene Jimenez-Del-Rio
Feb 2, 2013·Nutrition and Cancer·Miguel Mendivil-PerezCarlos Velez-Pardo
Citations
May 20, 2015·International Journal of Molecular Sciences·Zhicheng WangYuan Lu
Jul 3, 2015·Oxidative Medicine and Cellular Longevity·Hasahya TonyZeng Qiutang
Aug 4, 2016·Cell Biology International·Viviana Diaz-AguirreMarlene Jimenez-Del-Rio
Aug 30, 2016·Journal of Natural Products·Valéria GrobárováJan Černý
Jul 7, 2017·Medicinal Research Reviews·Matilde E LleonartAlex Lyakhovich
Apr 11, 2017·Frontiers in Pharmacology·Nikoletta KalenderoglouKaren L Wright
Jun 21, 2020·Cell Biology and Toxicology·Karolina KowalskaAgnieszka Wanda Piastowska-Ciesielska
Oct 25, 2020·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Miguel Mendivil-PerezMarlene Jimenez-Del-Rio
Feb 2, 2018·Anti-cancer Drugs·Shu LiShuang Li
Jun 17, 2020·Leukemia Research·Viviana Soto-MercadoCarlos Velez-Pardo